Use of Monte Carlo Simulations To Select Therapeutic Doses and Provisional Breakpoints of BAL9141

BAL9141, a new antimicrobial agent belonging to the class of parenteral pyrrolidinone-3-ylidenemethyl cephalosporins, is active against most gram-positive microorganisms, including methicillin-resistant variants (methicillin-resistant Staphylococcus aureus [MRSA] and methicillin-resistant Staphyloco...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mouton, Johan W., Schmitt-Hoffmann, Anne, Shapiro, Stuart, Nashed, Norman, Punt, Nieko C.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2004
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC400534/
https://ncbi.nlm.nih.gov/pubmed/15105125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.5.1713-1718.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares